Out-of-pocket health care expenditures among older Americans with dementia

Alzheimer Disease and Associated Disorders
Kenneth M LangaA R Herzog

Abstract

The number of older individuals with dementia will likely increase significantly in the next decades, but there is currently limited information regarding the out-of-pocket expenditures (OOPE) for medical care made by cognitively impaired individuals and their families. We used data from the 1993 and 1995 Asset and Health Dynamics Study, a nationally representative longitudinal survey of older Americans, to determine the OOPE for individuals with and without dementia. Dementia was identified in 1993 using a modified version of the Telephone Interview for Cognitive Status for self-respondents, and proxy assessment of memory and judgment for proxy respondents. In 1995, respondents reported OOPE over the prior 2 years for: 1) hospital and nursing home stays, 2) outpatient services, 3) home care, and 4) prescription medications. The adjusted mean annual OOPE was 1,350 US dollars for those without dementia, 2,150 US dollars for those with mild/moderate dementia, and 3,010 US dollars for those with severe dementia (p < 0.01). Expenditures for hospital/nursing home care (1,770 per year US dollars) and prescription medications (800 per year US dollars) were the largest OOPE components for those with severe dementia. We conclude that de...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Mar 1, 1992·Journal of the American Geriatrics Society·H G WelchE B Larson
Apr 15, 1993·The New England Journal of Medicine·J D Lubitz, G F Riley
Nov 13, 1996·JAMA : the Journal of the American Medical Association·C HoffmanH Y Sung
May 1, 1997·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·B J SoldoR B Wallace
May 1, 1997·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·A R Herzog, R B Wallace
Jun 13, 1998·Journal of the American Geriatrics Society·M WeinerG F Anderson
Feb 13, 1999·Journal of the American Geriatrics Society·R NewcomerR H Miller
Mar 4, 1999·The New England Journal of Medicine·S B Soumerai, D Ross-Degnan
Jul 30, 1999·Health Affairs·F Mullan
Sep 14, 1999·Journal of the American Geriatrics Society·E M GuttermanH Fillit
Mar 23, 2000·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·S CrystalR Kumar
Jun 16, 2000·Journal of the American Geriatrics Society·D H Taylor, F A Sloan
Sep 18, 2001·Health Affairs·C P ThomasS S Wallack
Sep 18, 2001·Journal of the American Geriatrics Society·W C McCormickE B Larson
Oct 12, 2001·JAMA : the Journal of the American Medical Association·A D FedermanJ Z Ayanian
Nov 28, 2001·Journal of General Internal Medicine·K M LangaA M Fendrick
Jan 31, 2002·Health Affairs·W HwangG Anderson
Mar 21, 2002·Journal of General Internal Medicine·M A SteinmanK E Covinsky
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Kristine YaffeKenneth E Covinsky
Sep 19, 2002·Health Services Research·James R Knickman, Emily K Snell
Dec 24, 2002·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Edith G WalshLisa F Berkmann

❮ Previous
Next ❯

Citations

Nov 22, 2007·Journal of General Internal Medicine·Tanya Ruff GureKenneth M Langa
Mar 15, 2008·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Padmaja AyyagariFrank A Sloan
Dec 15, 2015·Journal of the American Geriatrics Society·Zara CooperAmy S Kelley
Nov 17, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Adeline DelavandeKenneth M Langa
Jan 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·David R WeirMary Sano
Jul 18, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Sep 24, 2005·Health Services Research·A Lynn SnowJay Magaziner
Jun 20, 2006·International Journal of Geriatric Psychiatry·Martha SajatovicRosalinda V Ignacio
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katia NoyesAndrew W Dick
Feb 21, 2006·Biotechnology and Bioengineering·Jane A GilbertsonMichael S Kallos
Mar 23, 2017·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Daniel M GildenLee Bowman
May 24, 2014·Journal of the American Geriatrics Society·Lena M ChenArnold M Epstein
Jul 16, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Matthew GladmanLorne Zinman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
Edith G WalshLisa F Berkmann
Journal of the American Geriatrics Society
Annette L FitzpatrickCorinne Dulberg
© 2022 Meta ULC. All rights reserved